These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25294091)

  • 1. Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for 2 years.
    Suzuki T; Hirota T; Ogishima H; Umeda N; Kondo Y; Yokosawa M; Miki H; Tsuboi H; Matsumoto I; Sumida T
    Int J Rheum Dis; 2015 Jan; 18(1):108-10. PubMed ID: 25294091
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation between clinimetric approach and German US7 score in rheumatoid arthritis patients treated with tocilizumab: a pilot study.
    Terenzi R; Santoboni G; Bartoloni E; Alunno A; Luccioli F; Gerli R
    Clin Exp Rheumatol; 2015; 33(3):445. PubMed ID: 25937244
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience.
    Epis O; Casu C; Belloli L; Schito E; Filippini D; Muscarà M; Bruschi E
    Rheumatol Int; 2015 Sep; 35(9):1569-70. PubMed ID: 25773656
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in atherosclerosis markers during tocilizumab treatment in rheumatoid arthritis: preliminary results.
    Benucci M; Manfredi M; Saviola G; Sarzi-Puttini P; Atzeni F
    Clin Exp Rheumatol; 2013; 31(2):322-3. PubMed ID: 23380047
    [No Abstract]   [Full Text] [Related]  

  • 5. New biologics for rheumatoid arthritis.
    Choy E
    J R Coll Physicians Edinb; 2011 Sep; 41(3):234-7. PubMed ID: 21949922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline low modified health assessment questionnaire (MHAQ) predicts the state of remission estimated by clinical disease activity index and MHAQ at 1 year in tocilizumab-treated rheumatoid arthritis patients.
    Kawashiri S; Ueki Y; Migita K; Nakamura H; Aoyagi K; Kawakami A
    Clin Exp Rheumatol; 2014; 32(3):445. PubMed ID: 24850342
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of joint inflammation by MRI in patients with RA].
    Sumida T; Sugihara M; Hirota T; Horikoshi M; Suzuki T
    Clin Calcium; 2012 Feb; 22(2):193-8. PubMed ID: 22298072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of tocilizumab treatment with changes in measures of regional left ventricular function in rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging.
    Kobayashi Y; Kobayashi H; Giles JT; Hirano M; Nakajima Y; Takei M
    Int J Rheum Dis; 2016 Nov; 19(11):1169-1174. PubMed ID: 26480957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposing a method of regional assessment and a novel outcome measure in rheumatoid arthritis.
    Nishiyama S; Aita T; Yoshinaga Y; Kishimoto H; Toda M; Yoshihara Y; Miyoshi S; Manki A; Miyawaki S
    Rheumatol Int; 2012 Aug; 32(8):2569-71. PubMed ID: 21789609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic 'window of opportunity'.
    Greisen SR; Schelde KK; Rasmussen TK; Kragstrup TW; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Deleuran B; Hvid M
    Arthritis Res Ther; 2014 Sep; 16(5):434. PubMed ID: 25249397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmation of effectiveness of tocilizumab by ultrasonography and magnetic resonance imaging in biologic agent-naïve early-stage rheumatoid arthritis patients.
    Kawashiri SY; Suzuki T; Nakashima Y; Horai Y; Okada A; Iwamoto N; Ichinose K; Tamai M; Arima K; Nakamura H; Origuchi T; Uetani M; Aoyagi K; Kawakami A
    Mod Rheumatol; 2015; 25(6):948-53. PubMed ID: 24252054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review: the utility of magnetic resonance imaging for assessing structural damage in randomized controlled trials in rheumatoid arthritis.
    American College of Rheumatology Rheumatoid Arthritis Clinical Trials Task Force Imaging Group and Outcome Measures in Rheumatology Magnetic Resonance Imaging Inflammatory Arthritis Working Group
    Arthritis Rheum; 2013 Oct; 65(10):2513-23. PubMed ID: 23840013
    [No Abstract]   [Full Text] [Related]  

  • 13. One year in review: novelties in the treatment of rheumatoid arthritis.
    Guidelli GM; Barskova T; Brizi MG; Lepri G; Parma A; Talarico R; Cantarini L; Frediani B
    Clin Exp Rheumatol; 2015; 33(1):102-8. PubMed ID: 25719499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline levels of soluble interleukin-6 receptor predict clinical remission in patients with rheumatoid arthritis treated with tocilizumab: implications for molecular targeted therapy.
    Nishina N; Kikuchi J; Hashizume M; Yoshimoto K; Kameda H; Takeuchi T
    Ann Rheum Dis; 2014 May; 73(5):945-7. PubMed ID: 24336338
    [No Abstract]   [Full Text] [Related]  

  • 15. Sustained clinical remission and rate of relapse after tocilizumab withdrawal in patients with rheumatoid arthritis.
    Aguilar-Lozano L; Castillo-Ortiz JD; Vargas-Serafin C; Morales-Torres J; Sanchez-Ortiz A; Sandoval-Castro C; Padilla-Ibarra J; Hernandez-Cuevas C; Ramos-Remus C
    J Rheumatol; 2013 Jul; 40(7):1069-73. PubMed ID: 23729804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of tocilizumab combined with cyclosporine A in a patient with rheumatoid arthritis and concomitant chronic hepatitis C virus infection.
    Giannitti C; Fineschi I; Frediani B; Fioravanti A; Galeazzi M
    Clin Exp Rheumatol; 2013; 31(5):816. PubMed ID: 24021246
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of the usefulness of magnetic resonance imaging evaluation for rheumatoid arthritis treated with biological agents in the early phase: retrospective observation of abatacept and infliximab.
    Hirota T; Suzuki T; Hagiwara S; Ogishima H; Matsumoto I; Sumida T
    Clin Exp Rheumatol; 2014; 32(6):991. PubMed ID: 25190645
    [No Abstract]   [Full Text] [Related]  

  • 18. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.
    Brown AK; Quinn MA; Karim Z; Conaghan PG; Peterfy CG; Hensor E; Wakefield RJ; O'Connor PJ; Emery P
    Arthritis Rheum; 2006 Dec; 54(12):3761-73. PubMed ID: 17133543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of bilateral rheumatoid pleuritis successfully treated with tocilizumab.
    Ohtsuka K; Takeuchi K; Matsushita M; Aramaki T
    Mod Rheumatol; 2014 Nov; 24(6):1001-4. PubMed ID: 24533552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor-necrosis-factor inhibitors: 1 year follow-up with low-field extremity MRI.
    Suzuki T; Horikoshi M; Sugihara M; Hirota T; Ogishima H; Umeda N; Kondo Y; Tsuboi H; Hayashi T; Chino Y; Matsumoto I; Sumida T
    Mod Rheumatol; 2013 Jul; 23(4):782-7. PubMed ID: 22975733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.